Search
Capadenoson
go.drugbank.com/drugs/DB16118InvestigationalCapadenoson is under investigation in clinical trial NCT00518921 (Capadenoson in Angina Pectoris).
Categories: Adenosine A receptor agonistsHomidium
go.drugbank.com/drugs/DB17031InvestigationalHomidium is a group II compound with trypanocidal effects.[A253017]
Categories: Compounds used in a research, industrial, or household settingPhenylmercuric acetate
go.drugbank.com/drugs/DB17044ExperimentalPhenylmercuric acetate is an organomercurial compound used as a fungicide and slimicide.[A253082]
Categories: Compounds used in a research, industrial, or household settingDiaziquone
go.drugbank.com/drugs/DB17174ExperimentalCategories: Compounds used in a research, industrial, or household settingErgothioneine
go.drugbank.com/drugs/DB17614InvestigationalCategories: Compounds used in a research, industrial, or household settingPhosphocysteamine
go.drugbank.com/drugs/DB17640ExperimentalCategories: Compounds used in a research, industrial, or household settingAmmonium trichlorotellurate
go.drugbank.com/drugs/DB17740InvestigationalAmmonium trichlorotellurate is an investigational compound with anti-tumour and anti-inflammatory properties.
Categories: Compounds used in a research, industrial, or household settingMethamidophos
go.drugbank.com/drugs/DB14972ExperimentalMethamidophos is under investigation in clinical trial NCT03223753 (Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia in First Remission).
Categories: Compounds used in a research, industrial, or household settingCusatuzumab
go.drugbank.com/drugs/DB15100Investigational[A241975] Cusatuzumab is a humanized IgG1 antibody targeted against CD70. … An overexpression of CD70 can result in the proliferation of malignant cells and has been documented in a variety of solid and hematological malignancies.
Transfluthrin
go.drugbank.com/drugs/DB15117InvestigationalTransfluthrin is under investigation in clinical trial NCT02394522 (Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Zambia (SR-M-ZM)).
Categories: Compounds used in a research, industrial, or household setting